Subsequent Event	6 Months Ended
Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Event	NOTE 7 – SUBSEQUENT EVENT On February 16, 2018, the Securities and Exchange Commission announced the temporary suspension of trading in the Company’s securities from February 20, 2018 to March 5, 2018 because of questions regarding the accuracy of information in filings with the Commission, including a Form S-1 filed on January 11, 2018, a Form 8-K filed on January 4, 2018, and forms 10-K filed on September 20, 2016 and October 13, 2017 for the fiscal years ended June 30, 2016 and 2017, respectively, concerning, among other things, the company’s business operations and the identity of its officers.

Subsequent Event

6 Months Ended

Dec. 31, 2017

NOTE 7 – SUBSEQUENT EVENT

On February 16, 2018, the Securities and Exchange Commission announced the temporary suspension of trading in the Company’s securities from February 20, 2018 to March 5, 2018 because of questions regarding the accuracy of information in filings with the Commission, including a Form S-1 filed on January 11, 2018, a Form 8-K filed on January 4, 2018, and forms 10-K filed on September 20, 2016 and October 13, 2017 for the fiscal years ended June 30, 2016 and 2017, respectively, concerning, among other things, the company’s business operations and the identity of its officers.

EnzymeBioSystems 10-Q